Navigation Links
National Council on Disability Monthly Bulletin for November 2008
Date:12/8/2008

the organization's national email newsletter, "Justice For All."

Prior to joining AAPD full-time, Sommers was an AAPD consultant on a disability rights project for the American Civil Liberties Union. Sommers graduated in 2006 from the William and Mary School of Law in Williamsburg, Virginia. Prior to pursuing her legal career, Sommers worked for three years in marketing and copywriting in the health insurance industry and before that as a free-lance journalist for the Richmond Times-Dispatch. Sommers graduated summa cum laude and received her Bachelor's of Science degree from Virginia Tech University, where she was the opinions editor of the university's award-winning student newspaper.

Quarterly Meetings Update

NCD's Winter meeting will be held January 12-14, 2009, at the Chaparral Suites Resort in Scottsdale, Arizona.

In carrying out our mission, we believe it is vital to hear from communities around the country on what works and what does not for people with disabilities. Our agenda will include sessions on emergency preparedness, healthcare, employment, and several other subjects of interest to the disability community. We are delighted to have the opportunity to visit Arizona and learn firsthand about the experiences of people with disabilities from the Southwest. This is an opportunity to meet NCD members and staff and offer your comments during the public comment sessions, and we hope you will attend and participate.

Specific times are designated to receive public comment, supported by a toll-free call-in line, and input is encouraged and greatly appreciated. Individuals or organizations can also provide written comments by e-mail, fax, or mail. Public comment sessions will be held Monday, January 12 from 11:30 a.m. until noon (MST), on Tuesday, January 13 from 4:30 p.m. until 5:00 p.m., and on Wednesday, January 14 from 11:3
'/>"/>

SOURCE National Council on Disability
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
2. PA Department of Health Kicks Off National Influenza Immunization Week With Free Flu Shots at Hershey Bears Game
3. M. D. Anderson to hold first international conference on inflammatory breast cancer
4. Ramsey, N.J. Therapists Lectures to International Medical Professionals & Provides Treatment to Professional Athletes at Home and Abroad
5. Anthem Blue Cross and Blue Shield in New Hampshire Ranks Among Top Insurers on U.S. News & World Report / National Committee for Quality Assurance Best Health Plans List
6. NSF International Offers Answers to Rising Toy Safety Concerns
7. John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally
8. PRA International Expands European Presence With Opening of Munich Office
9. Friendly Bacteria Improve Health Segment Broadcasts On The National Medical Report
10. Allied National Partners With Healthplace America to Provide Significant Healthcare Savings
11. New Jerseys Mayors Wellness Campaign Goes National!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...nderstanding Brain Wiring and Diseases ,, WASHI...my Schmahmann, Professor of Neurology at Harvard M... General Hospital in Boston, on Thursday, November...w field of study called "Connectivity" at the laun...n is an award-winning leader in the field of the c...
(Date:11/20/2009).../ -- Following a recall by Unilever The Stop &...s Country Crock ® Side Dishes DELUXE Cheddar ...e Dishes DELUXE Four Cheese Pasta due to an undecl...ates and UPCs are affected: ,, Shedd,s Country...Rice 21 oz, UPC 027400218316, Best By NOV 29 09 th...
(Date:11/20/2009)...FirstCall/ -- Centene Corporation (NYSE: CNC )...of America Merrill Lynch 2009 Credit Conference, t...Hotel Times Square in New York City. ,, Centene... Eastern Time. Investors and other interested part...presentation at: http://www.veracast.com/webcasts...
(Date:11/20/2009)...-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI ) ...dio Reports: What Every Women Needs to Know About...n journalist Perri Peltz. ,, (Logo: http://ww...,, Doctor Radio Reports: What Every Woman Ne...21 live at 10:00 am ET on Doctor Radio , SIRIUS c...
(Date:11/20/2009)...gency medical service (EMS) providers in the Unite...ts each year. Only 5 to 10 percent of people who ...y cardiopulmonary resuscitation (CPR) provided by ...etter patient outcome. The Resuscitation Outcomes... network to study prehospital treatments for cardi...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...sue swelling better than steroids, team says , ...-angiogenesis drugs reduce edema (swelling of brai...oblastomas, a new study suggests. , Anti-angiogene...ospital team found that the experimental anti-angi...
...ill be made available closer to the meeting date. ...ance of the meeting as well as during the meeting....esearch Council of the National Academy of Science...ip of more than 5,700 scientists is representative...
... April 2 /PRNewswire-Asia-FirstCall/ -- Genesis,Ph...d: GNPH) ("Genesis" or the,"Company"), a U.S. phar...n the,People,s Republic of China, today affirmed i...e guidance for its fiscal year ending June,30, 200...
...e Treatment by a Podiatrist May Lead to Long-Term ...oot problems such as bunions, corns and dry, crack...e particular ailment -- heel pain -- stands out am...20 Americans aged 18 and older, found that 39 perc...
... Corticon offers special pricing on patent-pe...nd managing engaging self-service web applications...EB) April 2, 2009 -- Corticon Technologies, Inc. (...nar about, its patent-pending Corticon DialogsTM ...
... Celebrity Stylist, Lauri Eisenberg, Offers H...n Doesn,t Control Your Wardrobe , ...you,d never consider wearing silk or even solid co... waterworks going on underneath, then perspiration...
Other Medicine News:Health News:Drug Improves Survival in Mice With Brain Tumors 2Health News:Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009 2Health News:Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009 3Health News:Survey Shows Nearly 40 Percent of Americans Reel From Heel Pain 2Health News:Corticon Shows Business Transformation Potential of Dialogs, The First Intelligent Interactions Platform, at April 23 Webinar 2Health News:Corticon Shows Business Transformation Potential of Dialogs, The First Intelligent Interactions Platform, at April 23 Webinar 3Health News:Don't Sacrifice Style Because of Sweat 2Health News:Don't Sacrifice Style Because of Sweat 3Health News:Don't Sacrifice Style Because of Sweat 4
(Date:11/20/2009)...irstCall/ -- Medco Health Solutions, Inc (NYSE: ... American healthcare through an advanced, wired ph...quality clinical care and fundamentally bending th...or the benefit of patients and payors alike. ,,...ts strategy enable "Smarter Medicine" to help addr...
(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Pipettes & Pipettors - A Global Market P...164373/Pipettes--Pipettors---A-Global-Market-Persp...r&utm_campaign=prnewswire ,, Pipettes and...research laboratory. Large-scale applications in l...
(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Medical Adhesives and Sealants - A US Market...242/Medical-Adhesives-and-Sealants---A-US-Market-R...&utm_campaign=prnewswire ,, The use of me...e in medical devices and equipments. Cutting edge ...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2Sigma Aldrich to Present at the UBS Global Life Sciences Conference on Monday September 21 2009 14064 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 3
...07 - Clinical results from a,Phase II study presen...ciety (AHS) annual meeting showed that MK-0974, an...ide (CGRP),receptor antagonist, significantly impr...ompared to placebo, and the relief was,sustained t...ted in,the study. Responses specific to other meas...
... weeks achieved an SVR rate at,least comparable to...e favorable quality-of-life scores -, ROCKVILLE, M...Genome Sciences, Inc. today announced the top-line...uferon(R) (albinterferon alfa-2b),in combination w...otype 1 chronic hepatitis C. The Company expects t...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
Lumenis 950 Slit Lamp
Novus 3000 532 nm Laser System
Selecta Duo Photocoagulator Combination Laser
EnTrust Single Chamber ICD
Medicine Products: